MTAP/CDKN2Aが削除されたがんにおけるメチオニンの代謝障害は,PRMT5への依存につながります
Konstantinos J Mavrakis1, E Robert McDonald1, Michael R Schlabach1
1Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
まとめ
MTAPが削除されたがんはMTAを蓄積し,PRMT5を阻害する. これはPRMT5阻害に対する脆弱性を生み出し,これらの腫瘍に対する潜在的な治療としてPRMT5阻害剤を示唆している.
科学分野:
- 腫瘍学
- 生物化学
- 癌 の 遺伝子
背景:
- 5-メチルチオアデノシンリン酸化物 (MTAP) はメチオニンの回収経路において極めて重要です.
- MTAP遺伝子の欠失は,CDKN2A腫瘍抑制遺伝子の近くにあるため,ヒトの癌では一般的です.
研究 の 目的:
- 癌におけるMTAP消去の機能的影響を調査する.
- MTAP欠乏がんを標的とした治療戦略を特定する.
主な方法:
- 390のがん細胞系モデルを対象とした大規模な短いヘアピンRNA (shRNA) スクリーン.
- MTAPが削除された細胞におけるメチルチオアデノシン (MTA) の蓄積の分析
- PRMT5メチルトランスファーゼの活性と細胞活性の評価
主要な成果:
- MTAP欠乏した癌細胞は,PRMT5が枯渇すると生存能力が低下します.
- MTAPが削除された細胞に蓄積されたMTAはPRMT5メチルトランスファーゼの活性を抑制する.
- MTAPの消去は,PRMT5の抑制に細胞を敏感にし,MTAPの再導入は,この依存性を救済する.
結論:
- MTAが削除されたがんのMTA蓄積は,PRMT5の低形状状態につながり,PRMT5抑制に対する感受性を生み出します.
- PRMT5阻害剤は,MTAP/CDKN2Aが削除された腫瘍に対する有望な治療法です.
関連する概念動画
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression
1.6K
1.6K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Overview of Protein Metabolism
4.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.6K


